Wafergen Bio Systems Stock Market Capitalization
WaferGen Bio systems fundamentals help investors to digest information that contributes to WaferGen Bio's financial success or failures. It also enables traders to predict the movement of WaferGen Stock. The fundamental analysis module provides a way to measure WaferGen Bio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to WaferGen Bio stock.
WaferGen |
WaferGen Bio systems Company Market Capitalization Analysis
WaferGen Bio's Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Current WaferGen Bio Market Capitalization | 26.22 M |
Most of WaferGen Bio's fundamental indicators, such as Market Capitalization, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, WaferGen Bio systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
CompetitionBased on the recorded statements, the market capitalization of WaferGen Bio systems is about 26.22 M. This is much higher than that of the sector and significantly higher than that of the Market Capitalization industry. The market capitalization for all United States stocks is notably lower than that of the firm.
WaferGen Market Capitalization Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses WaferGen Bio's direct or indirect competition against its Market Capitalization to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of WaferGen Bio could also be used in its relative valuation, which is a method of valuing WaferGen Bio by comparing valuation metrics of similar companies.WaferGen Bio is currently under evaluation in market capitalization category among related companies.
WaferGen Fundamentals
| Return On Asset | -90.11 | |||
| Profit Margin | (175.04) % | |||
| Operating Margin | (171.93) % | |||
| Current Valuation | 16.04 M | |||
| Shares Outstanding | 3.8 M | |||
| Shares Owned By Insiders | 19.50 % | |||
| Shares Owned By Institutions | 5.80 % | |||
| Number Of Shares Shorted | 240.41 K | |||
| Price To Earning | (1.16) X | |||
| Price To Book | 12.86 X | |||
| Price To Sales | 1.99 X | |||
| Revenue | 9.24 M | |||
| Gross Profit | 3.95 M | |||
| Net Income | (20.85 M) | |||
| Cash And Equivalents | 5.15 M | |||
| Cash Per Share | 1.36 X | |||
| Total Debt | 2.94 M | |||
| Debt To Equity | 0.80 % | |||
| Current Ratio | 1.82 X | |||
| Cash Flow From Operations | (13.54 M) | |||
| Earnings Per Share | (5.93) X | |||
| Number Of Employees | 55 | |||
| Beta | 0.91 | |||
| Market Capitalization | 26.22 M | |||
| Total Asset | 11.39 M | |||
| Retained Earnings | (119.81 M) | |||
| Working Capital | 3.9 M | |||
| Current Asset | 8.68 M | |||
| Current Liabilities | 4.77 M | |||
| Z Score | -9.2 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards WaferGen Bio in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, WaferGen Bio's short interest history, or implied volatility extrapolated from WaferGen Bio options trading.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the WaferGen Bio systems information on this page should be used as a complementary analysis to other WaferGen Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in WaferGen Stock
If you are still planning to invest in WaferGen Bio systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the WaferGen Bio's history and understand the potential risks before investing.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |